Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Total Liabilities (2019 - 2025)

Korro Bio's Total Liabilities history spans 7 years, with the latest figure at $62.1 million for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities fell 5.71% year-over-year to $62.1 million, compared with a TTM value of $62.1 million through Dec 2025, down 5.71%, and an annual FY2025 reading of $62.1 million, down 5.71% over the prior year.
  • Total Liabilities for Q4 2025 was $62.1 million at Korro Bio, down from $62.5 million in the prior quarter.
  • The five-year high for Total Liabilities was $65.8 million in Q4 2024, with the low at $8.9 million in Q4 2022.
  • Average Total Liabilities over 5 years is $51.1 million, with a median of $54.1 million recorded in 2021.
  • Year-over-year, Total Liabilities crashed 83.66% in 2022 and then skyrocketed 564.91% in 2024.
  • Tracing KRRO's Total Liabilities over 5 years: stood at $54.5 million in 2021, then tumbled by 83.66% to $8.9 million in 2022, then skyrocketed by 480.83% to $51.8 million in 2023, then rose by 27.19% to $65.8 million in 2024, then decreased by 5.71% to $62.1 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Total Liabilities are $62.1 million (Q4 2025), $62.5 million (Q3 2025), and $65.3 million (Q2 2025).